The Missing Metric: Smartphone-Powered Kidney Test to Improve Health Plan Risk and Quality Measures

A simple urine test can provide an early warning for chronic kidney disease (CKD) before it becomes symptomatic. However, the albumin-to-creatinine ratio (ACR) test rates for the 75 million Americans at-risk are as low as 20% on average, allowing millions of cases to go undiscovered. Test rates are especially low among people of color and underserved populations, who are disproportionately affected by the disease. With CKD costing Medicare over $120 billion every year, the lack of early detection is also extremely costly. 

Effective management of CKD requires accurate risk assessment based on annual ACR testing for those at-risk for the disease. Early detection has substantial health and financial benefits, as well as the ability to prevent and combat the web of complications and comorbidities associated with CKD. But numerous barriers contribute to current low testing rates, such as access, mobility, location, and lack of awareness. 

In this paper, you’ll learn about current care gaps, why ACR is a critical data point for health plans, and how smartphone-powered home testing can help raise adherence, improve risk assessment and quality metrics, and reduce the cost of care. You’ll also be introduced to Minuteful Kidney, the first and only FDA-cleared, smartphone-powered at-home ACR test. By removing the barriers to testing, the service engages members and dramatically boosts test adherence.  

    All information that you supply is protected by our Privacy Policy.
    In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
    By submitting your information you agree to our Terms of Use.
    Third party cookies may be placed, to serve more relevant ads when you browse the web.
    You can learn more about those ads here.

    By selecting the “yes” option when filling out the above form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and opt-out and information removal. Once your information has been processed by Illumina, communication preferences and opt-out can be managed directly on the Illumina website. For more information, please refer to the Illumina privacy policy.